Cascadian Therapeutics Inc
CASC · Chemicals & Drugs · NASDAQ · in our data November 19, 1991 to March 8, 2018 (26.3 years)
The first trading day in our data for Cascadian Therapeutics Inc is November 19, 1991 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on March 2, 2000, the market valued it at $860 million. It ended in a collapse: the last trade was $10.02, -98.9% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 1991. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2018: Chemicals & Drugs
- Praxair, Inc. peaked at $48.6 billion
- Bioverativ Inc peaked at $11.4 billion
- Juno Therapeutics Inc peaked at $10.1 billion
- Avexis Inc peaked at $8.0 billion
- Foundation Medicine Inc peaked at $5.1 billion
- Endocyte Inc peaked at $2.0 billion
